EMCDDA Home
  • EN
Search

Inter-American Drug Abuse Control Commission (CICAD)

The Inter-American Drug Abuse Control Commission (CICAD) was established by the General Assembly of the Organization of American States (OAS) in 1986 as the Western Hemisphere's policy forum on all aspects of the drug problem. CICAD's core mission is to strengthen the human and institutional capabilities and harness the collective energy of its member states to reduce the production, trafficking and use and abuse of drugs in the Americas.

CICAD-EMCDDA cooperation

Wolfgang Götz, EMCDDA Director, and James Mack, Executive Secretary of Inter-American Drug Abuse Control Commission (CICAD), at the UN Commission on Narcotic Drugs (CND) in Vienna (2010)

Cooperation between CICAD-OAS and the EMCDDA was already foreseen in the EU/Latin America/Caribbean Action Plan formally adopted by the Heads of State and Government Summit held in Rio de Janeiro on 28 June 1999.

In October 2000, the EMCDDA and CICAD-OAS signed a Memorandum of Understanding formally establishing cooperation between the two organisations. This Memorandum represents a major step forward in national, European and international efforts to combat the global drug problem. Cooperation between the two organisations enables CICAD and the EMCDDA to jointly improve the collection and analysis of data and documentation on drugs; to develop and promote uniform data/comparison and documentation and analysis methods; and to intensify the dissemination of information. It is also aimed at coordinating their efforts to achieve the best use of available information and to ensure the most effective utilisation of their resources to this end.

The Memorandum unites the EMCDDA and CICAD-OAS in:

  • improving the collection and analysis of data
  • developing and promoting data-comparison methods; and
  • enhancing the dissemination of information.

The cooperation involves the EMCDDA’s participation as an observer in CICAD regular sessions and CICAD experts in EU experts meetings on an ad hoc basis as well as the participation of EMCDDA staff in CICAD technical and specific meetings, including special events such as the Drugs Summits of European, Latin American and Caribbean Mayors and Cities.

The two organisations are currently preparing a handbook on National Drug Observatories to be jointly published in October 2010. This handbook is a significant part of a strategic partnership with the aim to further support the establishment of a national monitoring capacity in their respective member states.

On 21 September 2010, James Mack, Executive Secretary of CICAD, visited the EMCDDA in Lisbon for talks with EMCDDA Director Wolfgang Götz. The focus of the visit was the endorsement of a new EMCDDA–CICAD work programme for 2011–13. Strategic objectives outlined in the three-year plan include: strengthening regional and international monitoring systems; harmonising and developing indicators in the areas of drug supply and demand; and supporting the establishment of national drug monitoring centres and drug information networks.

Contact information

CICAD

1889 F Street, N.W.
Washington, DC 20006
U.S.A.

Phone:
+1 2024583179
Fax: +1 2024583658
Web: www.cicad.oas.org

Page last updated: Friday, 15 October 2010